This Breast Cancer Awareness Month, we want to highlight ways physicians can help patients protect their heart health during cancer treatment. While cancer therapies improve survival, they can increase cardiovascular risks. Early detection of cardiotoxicity is crucial in these cases. Advanced imaging, like MyoStrain?, helps physicians detect heart damage early and monitor cardiac health over time—without interrupting cancer care. Learn more about the importance of early cardiotoxicity detection in cancer patients here: https://lnkd.in/gP425ae3
Myocardial Solutions
医疗设备制造业
Morrisville，North Carolina 1,328 位关注者
Providing novel MRI-based clinical informatics to transform cardiac care and standardize cardiac population management
关于我们
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain?, is a 10-minute, non-invasive heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. This novel cardiac tool leverages the power of high-speed MR imaging to help physicians detect and measure the effects of cardiotoxicity during cancer treatments. Physicians are using MyoStrain as a critical solution to holistically evaluate and protect patient heart health without interfering with oncology care. Today, with mounting evidence that many oncology treatments cause cardiotoxicity, new cancer patients and survivors are at an increased risk of cardiovascular disease. Unfortunately, diagnostics often cannot detect cardiotoxicity until symptoms occur, which is usually a sign of cardiac damage. The MyoStrain test works by quantifying segmental strain across 48 segments of the heart. This safe and rapid test produces a comprehensive report and MyoHealth? Score, a single number that helps indicate patient heart health and enables physicians to manage cardio-protection over time. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
- 网站
-
https://myocardialsolutions.com
Myocardial Solutions的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 11-50 人
- 总部
- Morrisville，North Carolina
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Cardio-Oncology、Oncology、Cancer Care、Heart Failure Management、Preventative Cardiology、Chest Pain Triage、Stress Testing、Early Detection、Proactive Diagnostics、Personalized Medicine、Value-based Care、COVID 19、Cardiac MRI、Cardio-Protection、Patient Management、Long-term Monitoring、Rapid Heart Function Testing和Non-invasive and Safe Test
地点
-
主要
获取路线
808 Aviation Pkwy
Suite 700
US，North Carolina，Morrisville，27560
Myocardial Solutions员工
动态
-
Precision matters in cardiac care. MyoStrain technology equips physicians with the tools to help proactively identify patients who can benefit from cardioprotective therapy before cardiotoxicity strikes. Elevate your clinical practice with MyoStrain. Hear more from physicians who have worked with MyoStrain by visiting the following page: https://lnkd.in/gZ6cBn8c
-
-
This Breast Cancer Awareness Month, we want to highlight the following PREFECT study and the impact it can have on cancer patient care. https://lnkd.in/g72qBA5C This study highlights the ability of MyoStrain and the MyoHealth risk score to provide physicians with information to help with early cardiotoxicity detection and proactive monitoring for breast cancer and lymphoma patients. Join us in raising awareness and sharing this vital research for improved patient outcomes. #BreastCancerAwarenessMonth2024
-
-
Thank you to our KOLs !! Drs. Juan Carlos Plana, Chairman of cardiology at Baylor College of Medicine, Houston, Tx. Dr. Alex Lyon, Clinical Lead for Cardio Oncolgy Service, Royal Brompton, London. Dr. Dan Lenihan, Founder and board member, ICOS. For participating and delivering a highly successful educational clinical symposium at GCOS 2024!!!
-
-
Join the 2nd Madrid Cardiac CT (Spectral) Academy tomorrow - Thursday, September 26 at Hospital Universitario Nuestra Se?ora del Rosario. Hear from Dr. Eliso Vano during the MyoStrain Session at 6:30 pm. Other courses will help physicians enhance their cardiac CT skills, and gain valuable insights into coronary arteriosclerotic disease, pre-TAVI studies, spectral CT imaging, and more. We look forward to seeing new and familiar faces.?
-
We want to extend a final thank you to the leaders and chairmen from various specialties—cardiology, oncology, radiology, and cardiac imaging—for delivering such powerful presentations at our panel discussion last week. Your work with MyoStrain is pushing the boundaries of cardiac care, and we are grateful for your continued partnership and dedication to innovation.
-
-
-
-
-
+4
-
-
A huge thank you to our partner, La Paz University Hospital, for leading the way with MyoStrain and hosting such a successful event last week! With 78 clinicians attending in person and 24 joining online, it was an inspiring day of education and innovation. The team also had the privilege of recognizing Dr. Javier Blazquez, Dr. Javier Alarcon, and Dr. Eliseo Vano with the first-ever MSI COE Awards for surpassing 1,000 MyoStrain tests. This is just the beginning of many more impactful sessions to come! #MyoStrain
-
-
MyoCardial Solutions is gearing up for the Global Cardio-Oncology tomorrow. We are looking forward to the panel discussion - Revolutionizing Cardio-Oncology care through CMR Innovation. Our expert panelists, including Dr. Alex Lyon (Clinical Lead for Cardio-Oncology Service) and Dr. Dan Lenihan (Founder and Board Member, International Cardio-Oncology Society), will be discussing how the MyoStrain can be used to optimize cardioprotective strategies. Learn more: https://www.gcos2024.com/
-
-
#GCOS2024 is right around the corner! Join Myocardial Solutions for this pivotal gathering, hosted by the Lillehei Heart Institute and the Masonic Cancer Center at the University of Minnesota. Myocardial Solutions will sponsor the Monday Lunch Symposium with speakers Dr. Alex Lyon (Clinical Lead for Cardio-Oncology Service) and Dr. Dan Lenihan (Founder and Board Member, International Cardio-Oncology Society), to address crucial clinical topics and enhance the cardiovascular health of cancer patients. Let’s collaborate to push the boundaries of cardio-oncology further. hashtag #GCOS2024 hashtag #CardioOncology hashtag #HealthcareInnovation
-
-
I Jornada Multidisciplinar de Myostrain - La Paz - 17 de Septiembre 2024 -Tambien puedes seguir el evento por Zoom- https://lnkd.in/dCZ-id29 - ID de reunión: 862 3085 3933
I Jornada Multidisciplinar de Myostrain - La Paz
www.dhirubhai.net